Teladoc Health (NYSE:TDOC) Shares Gap Down – Here’s What Happened

Shares of Teladoc Health, Inc. (NYSE:TDOC) gapped down before the market opened on Thursday . The stock had previously closed at $9.18, but opened at $7.66. Teladoc Health shares last traded at $6.7160, with a volume of 4,632,736 shares changing hands.

Teladoc Health News Summary

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Teladoc reported a second-quarter loss of $0.21 per share, better than analysts’ expected loss of $0.24. Operating cash flow was $64.7 million, while management’s efficiency efforts helped narrow the first-half net loss. Teladoc Health Reports Second Quarter 2026 Results
• Positive Sentiment: The company said its Integrated Care segment showed stronger profitability, providing some evidence that cost controls and operational improvements are supporting the path toward better earnings even as overall sales remain pressured. Do Teladoc’s Weaker Q2 Results Signal a Turning Point in Its Profit Path?
• Neutral Sentiment: Teladoc ended the quarter with $774.3 million in cash and cash equivalents, offering liquidity for ongoing operations and restructuring initiatives. However, the company remains unprofitable, with a negative net margin and negative return on equity. Teladoc Health Q2 2026 Earnings
• Negative Sentiment: Second-quarter revenue fell 4% year over year to $606.9 million, below the approximately $615.4 million consensus estimate. The company also posted a $38.9 million net loss, compared with a $0.19-per-share loss in the year-ago quarter. Teladoc Stock Plummets on Revenue Miss, Lowered Outlook
• Negative Sentiment: Teladoc reduced its full-year 2026 revenue outlook to roughly $2.4 billion, below Wall Street’s estimate of about $2.5 billion. Third-quarter revenue guidance of $569 million to $609 million also trails the $629.1 million consensus, while the projected per-share loss is wider than expected. Why Teladoc Health Stock Is Dropping Following Soft Q3 Outlook
• Negative Sentiment: Management cited shifting demand and lower cash-pay revenue at BetterHelp, its mental-health services unit, as a key reason for cutting the outlook. The weakness raises concerns about the timing of a sustainable return to revenue growth. Teladoc Tumbles on Revenue Forecast Cut as BetterHelp Demand Shifts Hurt

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Citigroup raised their target price on Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. Bank of America raised their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research report on Tuesday, July 7th. Weiss Ratings upgraded shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Finally, Canaccord Genuity Group raised their target price on shares of Teladoc Health from $10.00 to $11.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Five equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average price target of $7.57.

Teladoc Health Price Performance

The stock has a 50 day moving average of $8.21 and a two-hundred day moving average of $6.55. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80. The stock has a market cap of $1.22 billion, a PE ratio of -6.94 and a beta of 2.10.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.03. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company had revenue of $606.93 million during the quarter, compared to analyst estimates of $615.44 million. During the same period in the prior year, the firm earned ($0.19) earnings per share. The business’s quarterly revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. Equities analysts anticipate that Teladoc Health, Inc. will post -0.92 EPS for the current year.

Insider Activity

In other Teladoc Health news, insider Adam C. Vandervoort sold 7,906 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $60,322.78. Following the transaction, the insider directly owned 110,261 shares in the company, valued at approximately $841,291.43. The trade was a 6.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Charles Divita III sold 19,132 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $145,977.16. Following the sale, the chief executive officer directly owned 389,894 shares in the company, valued at approximately $2,974,891.22. This trade represents a 4.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 39,195 shares of company stock worth $299,058 over the last three months. 0.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC grew its holdings in shares of Teladoc Health by 694.5% during the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after buying an additional 4,945 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in Teladoc Health by 177.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after acquiring an additional 2,810 shares in the last quarter. IFP Advisors Inc boosted its position in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after acquiring an additional 3,210 shares during the period. International Assets Investment Management LLC acquired a new stake in Teladoc Health during the 4th quarter worth about $45,000. Finally, Van ECK Associates Corp grew its stake in Teladoc Health by 101.4% during the 4th quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock valued at $64,000 after acquiring an additional 4,607 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.